• EN
  • DA

Danish NationalResearch Database

  • Publications
  • Researchers
Example Finds records
water{} containing the word "water".
water supplies"{}" containing the phrase "water supplies".
author:"Doe, John"author:"{}" containing the phrase "Doe, John" in the author field.
title:IEEEtitle:{} containing the word "IEEE" in the title field.
bech{} containing the word "bech".
marie bech"{}" containing the phrase "marie bech".
orcid:0000-0002-5429-5292orcid:{} Having a particular ORCID
Need more help? Advanced search tutorial
  • Selected (0)
  • History

CYP2C19*17 increases clopidogrel-mediated platelet inhibition but does not alter the pharmacokinetics of the active metabolite of clopidogrel

    • Save to Mendeley
    • Export to BibTeX
    • Export to RIS
    • Email citation
Authors:
  • Pedersen, Rasmus Steen ;
    Close
    unknown
  • Nielsen, Flemming ;
    Close
    Environmental Medicine, Department of Public Health, Faculty of Health Sciences, SDU
  • Stage, Tore Bjerregaard ;
    Close
    Clinical Pharmacology and Pharmacy, Department of Public Health, Faculty of Health Sciences, SDU
  • Vinholt, Pernille Just ;
    Close
    Orcid logo0000-0002-2035-0169
    Clinical Biochemistry, Department of Clinical Research, Faculty of Health Sciences, SDU
  • Achwah, Alaa Bilal El ;
    Close
    University of Southern Denmark
  • Damkier, Per ;
    Close
    Orcid logo0000-0003-0591-7187
    Clinical Biochemistry, Department of Clinical Research, Faculty of Health Sciences, SDU
  • Brøsen, Kim
    Close
    Clinical Pharmacology and Pharmacy, Department of Public Health, Faculty of Health Sciences, SDU
DOI:
10.1111/1440-1681.12297
Abstract:
The aim of the present study was to determine the impact of CYP2C19*17 on the pharmacokinetics and pharmacodynamics of the active metabolite of clopidogrel and the pharmacokinetics of proguanil. Thus, we conducted an open-label two-phase cross-over study in 31 healthy male volunteers (11 CYP2C19*1/*1, 11 CYP2C19*1/*17 and nine CYP2C19*17/*17). In Phase A, the pharmacokinetics of the derivatized active metabolite of clopidogrel (CAMD) and platelet function were determined after administration of a single oral dose of 600 mg clopidogrel (Plavix; Sanofi-Avensis, Horsholm, Denmark). In Phase B, the pharmacokinetics of proguanil and its metabolites cycloguanil and 4-chlorphenylbiguanide (4-CPB) were determined in 29 of 31 subjects after a single oral dose of 200 mg proguanil given as the combination drug Malarone (GlaxoSmithKline Pharma, Brondby, Denmark). Significant correlations were found between the area under the time-concentration curve (AUC0-∞ ) of CAMD and both the absolute ADP-induced P2Y12 receptor-activated platelet aggregation (r = -0.60, P = 0.0007) and the percentage inhibition of aggregation (r = 0.59, P = 0.0009). In addition, the CYP2C19*17/*17 and CYP2C19*1/*17 genotype groups had significantly higher percentage inhibition of platelet aggregation compared with the CYP2C19*1/*1 subjects (geometric mean percentage inhibition of 84%, 73% and 63%, respectively; P = 0.014). Neither the absolute ADP-induced P2Y12 receptor-activated platelet aggregation, exposure to CAMD nor the pharmacokinetic parameters of proguanil, cycloguanil and 4-CPB exhibited any significant differences among the genotype groups. In conclusion, carriers of CYP2C19*17 exhibit higher percentage inhibition of platelet aggregation, but do not have significantly lower absolute P2Y12 receptor-activated platelet aggregation or higher exposure to the active metabolite after a single oral administration of 600 mg clopidogrel.
Type:
Journal article
Language:
English
Published in:
Clinical and Experimental Pharmacology and Physiology, 2014, Vol 41, Issue 11, p. 870-78
Keywords:
Area Under Curve; Cross-Over Studies; Cytochrome P-450 CYP2C19; Dose-Response Relationship, Drug; Healthy Volunteers; Humans; Male; Platelet Aggregation; Polymorphism, Single Nucleotide; Proguanil; Prospective Studies; Purinergic P2Y Receptor Antagonists; Substrate Specificity; Ticlopidine; Time Factors
Main Research Area:
Medical science
Publication Status:
Published
Review type:
Peer Review
Submission year:
2014
Scientific Level:
Scientific
ID:
269927916

Full text access

  • Doi Get publisher edition via DOI resolver
Checking for on-site access...

On-site access

At institution

  • University southern denmark

Metrics

Feedback

Sitemap

  • Search
    • Statistics
    • Tutorial
    • Data
    • FAQ
    • Contact
  • About
    • Institutions
    • Release History
    • Cookies and Personal Data
  • Open Access
    • The Danish Open Access Indicator

Copyright © 1998–2018.

Fivu en